Literature DB >> 27432069

Type 2 diabetes: A 21st century epidemic.

Lindsay M Jaacks1, Karen R Siegel2, Unjali P Gujral3, K M Venkat Narayan4.   

Abstract

Around 415 million people around the world have diabetes (9% of adults), and the vast majority live in low- and middle-income countries. Over the next decade, this number is predicted to increase to 642 million people. Given that diabetes is a major cause of mortality, morbidity, and health care expenditures, addressing this chronic disease represents one of the greatest global health challenges of our time. The objectives of this article are three-fold: (1) to present data on the global burden of type 2 diabetes (which makes up 87-91% of the total diabetes burden), both in terms of prevalence and incidence; (2) to give an overview of the risk factors for type 2 diabetes, and to describe obesity and the developmental origins of disease risk in detail; and (3) to discuss the implications of the global burden and point out important research gaps.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  impaired fasting glucose; impaired glucose tolerance; incidence; obesity; prevalence; type 2 diabetes

Mesh:

Year:  2016        PMID: 27432069     DOI: 10.1016/j.beem.2016.05.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  58 in total

1.  Renal tubular ACE-mediated tubular injury is the major contributor to microalbuminuria in early diabetic nephropathy.

Authors:  Masahiro Eriguchi; Mercury Lin; Michifumi Yamashita; Tuantuan V Zhao; Zakir Khan; Ellen A Bernstein; Susan B Gurley; Romer A Gonzalez-Villalobos; Kenneth E Bernstein; Jorge F Giani
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-29

2.  Metformin induces osteoblastic differentiation of human induced pluripotent stem cell-derived mesenchymal stem cells.

Authors:  Ping Wang; Tao Ma; Dong Guo; Kevin Hu; Yan Shu; Hockin H K Xu; Abraham Schneider
Journal:  J Tissue Eng Regen Med       Date:  2017-08-11       Impact factor: 3.963

3.  Mysteries of type 2 diabetes: the Indian Elephant meets the Chinese Dragon.

Authors:  E C Rhodes; U P Gujral; K M Narayan
Journal:  Eur J Clin Nutr       Date:  2017-06-14       Impact factor: 4.016

4.  Clinical and metabolomics analysis of hepatocellular carcinoma patients with diabetes mellitus.

Authors:  Hongping Xia; Jianxiang Chen; Karthik Sekar; Ming Shi; Tian Xie; Kam M Hui
Journal:  Metabolomics       Date:  2019-11-26       Impact factor: 4.290

5.  How do self-care maintenance, self-care monitoring, and self-care management affect glycated haemoglobin in adults with type 2 diabetes? A multicentre observational study.

Authors:  Diletta Fabrizi; Paola Rebora; Michela Luciani; Stefania Di Mauro; Maria Grazia Valsecchi; Davide Ausili
Journal:  Endocrine       Date:  2020-06-05       Impact factor: 3.633

Review 6.  Energy sensing pathways: Bridging type 2 diabetes and colorectal cancer?

Authors:  Juhong Yang; Reiko Nishihara; Xuehong Zhang; Shuji Ogino; Zhi Rong Qian
Journal:  J Diabetes Complications       Date:  2017-04-13       Impact factor: 2.852

7.  Targeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy.

Authors:  Shyam Sundar Nandi; Paras Kumar Mishra
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

8.  Examining the Relationship and Prognostic Implication of Diabetic Status and Extracellular Matrix Expansion by Cardiac Magnetic Resonance.

Authors:  Mohammad A Khan; Eric Y Yang; Duc T Nguyen; Faisal Nabi; Jeremy Hinojosa; Maria Jabel; Sherif F Nagueh; Edward A Graviss; Dipan J Shah
Journal:  Circ Cardiovasc Imaging       Date:  2020-07-15       Impact factor: 7.792

9.  Mss51 deletion enhances muscle metabolism and glucose homeostasis in mice.

Authors:  Yazmin I Rovira Gonzalez; Adam L Moyer; Nicolas J LeTexier; August D Bratti; Siyuan Feng; Congshan Sun; Ting Liu; Jyothi Mula; Pankhuri Jha; Shama R Iyer; Richard M Lovering; Brian O'Rourke; Hye Lim Noh; Sujin Suk; Jason K Kim; George K Essien Umanah; Kathryn R Wagner
Journal:  JCI Insight       Date:  2019-10-17

Review 10.  FGF1 - a new weapon to control type 2 diabetes mellitus.

Authors:  Emanuel Gasser; Christopher P Moutos; Michael Downes; Ronald M Evans
Journal:  Nat Rev Endocrinol       Date:  2017-06-30       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.